OWL

• Misión, Visión, Estrategia, Líneas de actividad
• Tecnología OWL
• Certificaciones
  - Certificación de laboratorio
  - ISO 9001
  
• Equipo de dirección
• Centros colaboradores
• Inversores
• Patentes generales
• Artículos científicos
• Carreras profesionales

Usuario Contraseña

• ¿Olvidó la contraseña?
• Solicitar registro

Selección de artículos científicos

Todos los artículos científicos de los que son autores los investigadores de OWL se pueden consultar a través de la página Web del servicio PubMed del National Center for Biothecnology Information: www.ncbi.nlm.nih.gov/pubmed

Obesity-dependent metabolic signatures associated with nonalcoholic Fatty liver disease progression.

Barr J et al.

Journal of Proteome Research 2012;11(4),2521-32

A metabolic signature predicts biological age in mice.

Tomás-Loba A et al.

Aging Cell 2013;12(1):93-101

Solute carrier family 2 member 1 is involved in the development of nonalcoholic fatty liver disease.

Vazquez-Chantada M et al.

Hepatology 2013;57(2):505-14

Metabolomics Discloses Potential Biomarkers for the Noninvasive Diagnosis of Idiopathic Portal Hypertension.

Seijo S et al.

The American Journal of Gastroenterology 2013;108(6):926-32

Where Are We in the Search for Noninvasive Nonalcoholic Steatohepatitis Biomarkers?

Mato JM, Lu SC

Hepatology 54;4:1115-1117

Liquid Chromatography-Mass Spectrometry (LC/MS)-based parallel metabolic profiling of human and mouse model serum reveals putative biomarkers associated with the progression of non-alcoholic fatty liver disease.

Barr J et al.

Journal of Proteome Research 2010;9(9),4501-12

S-Adenosylmethionine in liver health, injury, and cancer

Lu SC, Mato JM.

Physiol Rev 2012; 92:1515-42.

Effect of vitrification on human oocytes: a metabolic profiling study

Dominguez F et al.

Fertility and Sterility 2013, 99(2):565-572

Serum UPLC-MS/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity

González E et al.

Metabolomics 2012;8(6):997-1011

Metabolomic modelling of drug toxicity. An activity of the MeliusProject.

Vazquez-Chantada M et al.

"Toxicology Letters" Volume 196S, 17 July 2010; S1-S352. ISSN 0378-4274.
2010 EUROTOX Gerhard-Zbinden Young Scientist Award for drug-oriented toxicological research

Ultra-Performance Liquid ChromatographyTM High Definition Mass Spectrometry (UPLCTM-HDMSTM) as a useful tool in predictive drug toxicology. An activity of Melius Proyect.

Barr J et al.

"Toxicology Letters" Volume 196S, 17 July 2010; S1-S352. ISSN 0378-4274.

Non-alcoholic steatohepatitis and animal models: understanding the human disease.

Varela-Rey M et al.

Int J Biochem Cell Biol. 2009 41(5):969-76.

S-adenosylmethionine and proliferation: new pathways, new targets.

Martínez-López N et al.

Biochem Soc Trans. 2008 36(5):848-52.

Loss of the glycine n-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.

Martínez-Chantar ML et al.

Hepatology. 2008 47(4):1191-9.

Methionine metabolism and liver disease.

Mato JM, Martínez-Chantar ML, Lu SC.

Annu Rev Nutr. 2008;28:273-93.

S-adenosylmethionine in cell growth, apoptosis and liver cancer.

Lu SC, Mato JM.

J Gastroenterol Hepatol. 2008 23 Suppl 1:S73-7.

Role of s-adenosyl-l-methionine in liver health and injury.

Mato JM, Lu SC.

Hepatology. 2007 45(5):1306-12.

Subir